Identifying Novel Therapeutic Approaches and Predictive Biomarkers for Castleman Disease

Identifying Novel
IIdiopathic multicentric Castleman disease (iMCD) is a hematologic illness involving cytokine-induced lymphoproliferation, systemic inflammation, cytopenias and life-threatening multi-organ dysfunction.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

Clinical and Genetic Determinants of Contralateral Breast Cancer in Newly Diagnosed Breast Cancer Patients

Ambry Genetics

This webinar will review clinical and genetic risk factors for contralateral breast cancer in patients who have been newly diagnosed with breast cancer. A specific focus on the role of family history and genetic mutations on contralateral breast cancer risk will be outlined. The role of risk models and how to apply these and other prediction tools in the clinical setting will be reviewed.
Watch Now

Patient-Preferred Trials

eyeforpharma

Clinical trial participants are no longer just numbers on a spreadsheet. They are customers, consumers, patients and people, with all their wonderful complexities, preferences and nuances. And they have a right to choose whether your trial is going to suit them.
Watch Now

New Tools to Advance CNS Drug Delivery

Business-review-webinars

This webinar will focus on the advantages of nasal powder formulations and on a non-human primate (NHP) model to quantify nose-to-brain delivery of a model compound, sumatriptan. The webinar will also compare pharmacokinetic advantages of nasal powders versus aqueous formulations, as well as in vitro results of nasal powder delivery.
Watch Now

2023 Pharma Digital Transformation

Digitalization in the pharmaceutical industry is a pervasive and persistent phenomenon that rapidly changes how patients engage with pharma and purchase drugs. The pandemic has just accelerated the changes which already began before
Watch Now

Spotlight

resources